The growing technological advancement coupled with increase in demand for biomedical research is expected to boost the High-Throughput Screening Market in future
As per the study initiated by Evolve Business Intelligence, The global High-Throughput Screening market size is expected to reach $39.45 Billion by 2028 growing at the CAGR of 11.50% from 2021 to 2028. Some of the major factors impacting the overall growth of the High-Throughput Screening market include growing demand for the discovery of the drug, an increase in demand for biomedical research, rise in technological advancement, High automation, and quick data processing, and among others. The restraining factor includes Deficiency of skilled professionals, and increase in capital investment.
Analyst's View
According to Evolve Business Intelligence, “the recent COVID scenario is expected to have a positive impact on High-Throughput Screening Market.  During covid pandemic, the spread of virus as impacted the people’s health. The demand for drugs discoveryhas been increasing in order to provide a solutions of covi-19. As High-Throughput Screening is used for drug discovery of numerous life-threatening diseases. The demand for High-Throughput Screening has been increase during pandemic.
Thermo Fisher Scientific is expected to hold the highest market share in High-Throughput Screening
Some of the key players in the High-Throughput Screening market include Thermo Fisher Scientific, Agilent Technologies, Inc., Danaher, PerkinElmer, Inc., and Others. In June 2021, Â Â Thermo Fisher Scientific Launches Collection Kit to Streamline Saliva Testing.
The High-Throughput Screening market report published today includes market revenue generated through the sale of Products & Services such as Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, Services, Label-free Technology, and 3D Cell Culture. The report also includes the analysis of the market based on Technology such as Cell-based Assays, 2D Cell Culture, Perfusion Cell Culture, Lab-on-a-chip (LOC), Ultrahigh-throughput Screening, and Bioinformatics. On the basis of application segment, the market is segmented as Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, and Others.
